Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
18F-FDG PET/CT
Differentiated thyroid cancer
Medullary thyroid cancer
TENIS
Thyroid cancer
Journal
PET clinics
ISSN: 1879-9809
Titre abrégé: PET Clin
Pays: United States
ID NLM: 101260152
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
pubmed:
9
3
2022
medline:
1
4
2022
entrez:
8
3
2022
Statut:
ppublish
Résumé
Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG PET/CT) plays an important role in the management of thyroid malignancies. Incidentally found FDG avid nodule needs further workup to rule out its malignant potential. 18F-FDG PET/CT has a proven role in detecting recurrent disease or the metastatic workup of the thyroglobulin elevated negative radioiodine scan (TENIS) scenario. In managing histologically aggressive carcinoma of the thyroid, 18F-FDG PET/CT has a proven role. The theranostic potential has been explored with PET/CT using 68Ga-SSA, 68Ga-PSMA,68Ga-FAPI, and 68Ga-DOTA-RGD. The 124I PET/CT role is just being investigated for better spatial resolution and helps in dosimetry.
Identifiants
pubmed: 35256297
pii: S1556-8598(21)00112-7
doi: 10.1016/j.cpet.2021.12.004
pii:
doi:
Substances chimiques
Gallium Isotopes
0
Gallium Radioisotopes
0
Iodine Radioisotopes
0
Iodine-124
0
gallium 68 PSMA-11
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Thyroglobulin
9010-34-8
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
265-283Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.